As AI-generated health trajectories become operational at scale, they present both an opportunity for improved outcomes and a call to manage unprecedented volumes of personal data responsibly
The challenge is to get these results into clinical practice, to get the drug used by the people who will benefit from it, who will live longer without dialysis, without heart attacks, without strokes, if they take this drug. Conducted between June 2019 and May 2021, the trial saw half of all patients receiving a 1 mg dose of semaglutide each week, and half receiving a placebo
for the typical higher-body-fat GLP-1 patient it usually lands inside the 1.6-2.0 g/kg total-BW range
their effects may be greater or smaller in cases of larger fibroids
Pharmacological interventions may be appropriate if lifestyle measures prove insufficient
Patients should be counselled about these potential side effects before initiating treatment, and healthcare professionals should monitor for tolerability throughout the treatment course
